- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07693478
Effect of Bioptron Light Therapy on Wound Healing After Caesarean Section
Study Overview
Status
Intervention / Treatment
Detailed Description
Wound healing process is important after cesarean section without complication and with short period of time; caesarean section (CS) wound complications represent a substantial burden to the health system and the prevention of such complications should be a healthcare priority in developing countries.
Delayed wound healing is when a wound takes longer than normal to heal, it has many hazards such as disruption and fluid collection (hematomas and seromas), adhesions, infection (abscess) and rupture of membranes.
Management and acceleration of wound healing after cesarean section are important for maternal and newborn care and breastfeeding. Many drugs used for this purpose, especially nonsteroidal anti-inflammatory drugs (NSAIDs) and opiates, have side effects including nausea, respiratory distress, gastrointestinal bleeding and itching.
Previous studies indicated using Bioptron light therapy to accelerate wound healing, it can be used as mono therapy. or as complementary therapy for wound healing and treating pain, Also, it can improve microcirculation, harmonize metabolic processes, reinforce the human defense system, stimulate regenerative processes of the entire organism, promote wound healing and relieve pain.
As a non-invasive intervention for wound healing, it enhances the whole individual's regenerative and reparative processes, promote wound healing, regulates vascular endothelial growth factor (VEGF). It also provides faster wound closure, enhanced wound epithelialization and greater scar tensile strength.
To our knowledge, there were few previous studies investigated and confirm the effect of Bioptron light therapy on wound healing in patients with diabetic wound and burn wound.
But until now there is no previous study investigates its effect on post cesarean section wound healing. so, this study will be the first one in this issue. Therefore, the results obtained from this study will be of valuable benefits for medical service organizations and increase body of knowledge of physical therapists in scientific field.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ghada Hamdy Abd Elmoamen, B.Sc
- Phone Number: +20 10 60132861
- Email: dodoh2034@gmail.com
Study Contact Backup
- Name: Manal Ahmed El Shafei, PhD
Study Locations
-
-
-
Menouf, Egypt
- A specialized surgical hospital in Shebin El-kom
-
Contact:
- Ghada Hamdy Abd Elmoamen, B.Sc
- Phone Number: +20 10 60132861
- Email: dodoh2034@gmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Post partum women delivered by cesarean section on their first 24 hours after operation.
- Their ages range from 25 to 30 years old.
- Their BMI will be less than 30 kg/m2.
- All females will be clinically diagnosed, confirmed and referred by the obstetricians.
- They are medically stable.
Exclusion Criteria:
- History of any radiotherapy or chemotherapy.
- History of diabetes.
- History of psychological problems.
- Acute infection in area treated.
- Skin disease or any disease leading to delayed wound healing, such as venous or arterial disease.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Standard postoperative medical care
Participants received standard postoperative medical care, including analgesics, antibiotics, antiseptics, and anti-inflammatory medications, as prescribed by the obstetrician, immediately after recovery from anesthesia.
|
Standard postoperative medical care consisting of analgesics, antibiotics, antiseptics, and anti-inflammatory medications prescribed by the treating obstetrician.
|
|
Experimental: Standard postoperative medical care + Bioptron Light Therapy
Participants received standard postoperative medical care in addition to Bioptron light therapy (480-3400 nm, energy density 2.4 J/cm², 15 minutes per session, one session daily for 5 consecutive days), initiated within the first 24 hours after cesarean section.
|
Standard postoperative medical care consisting of analgesics, antibiotics, antiseptics, and anti-inflammatory medications prescribed by the treating obstetrician.
Polarized polychromatic non-coherent light therapy (480-3400 nm, energy density 2.4 J/cm², power density 40 mW/cm², 15 minutes per session, once daily for 5 consecutive days), initiated within the first 24 hours after cesarean section.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wound surface area
Time Frame: 5 days
|
The wound surface area (cm²) will be measured by ultrasonography using the wound length × width method.
Ultrasound imaging will be performed using a 2.8-10 MHz transducer to objectively assess wound healing.
A reduction in wound surface area indicates improved wound healing.
|
5 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Wound healing (REEDA score)
Time Frame: 5 days
|
Wound healing will be evaluated using the REEDA scale, which assesses five clinical parameters: Redness, Edema, Ecchymosis, Discharge, and Approximation.
Each parameter is scored from 0 to 3, yielding a total score ranging from 0 to 15, with lower scores indicating better wound healing.
|
5 days
|
|
Wound healing questionnaire (WHQ) score
Time Frame: 5 days
|
Wound healing will be assessed using the validated Bluebelle Wound Healing Questionnaire (WHQ), which evaluates wound-related signs, symptoms, and wound care interventions following abdominal surgery.
Higher total scores indicate greater wound-related problems and delayed healing.
|
5 days
|
Collaborators and Investigators
Sponsor
Investigators
- Study Chair: Hala Mohamed Omara, PhD, Professor, Cairo University
- Study Director: Manal Ahmed El Shafei, PhD, Assist Professor, Cairo University
- Study Director: Sameh Hussien Samir, PhD, Professor, National Research Center
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T.REC/012/005904
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean Section; Complications, Wound, Dehiscence
-
Odense University HospitalHvidovre University Hospital; Smith & Nephew, Inc.; University of Southern Denmark and other collaboratorsCompletedSurgical Wound Infection | Cesarean Section; Dehiscence | Complications; Cesarean Section | Infection; Cesarean Section | Complications; Cesarean Section, Wound, Dehiscence | Wound; Rupture, Surgery, Cesarean SectionDenmark
-
Odense University HospitalHvidovre University Hospital; Smith & Nephew, Inc.; University of Southern Denmark and other collaboratorsCompletedSurgical Wound Infection | Cesarean Section; Dehiscence | Complications; Cesarean Section | Infection; Cesarean Section | Complications; Cesarean Section, Wound, Dehiscence | Wound; Rupture, Surgery, Cesarean SectionDenmark
-
Piazza della Vittoria 14 Studio Medico - Ginecologia...CompletedCesarean Section Complications | Cesarean Wound; DehiscenceItaly
-
Loyola UniversityMolnlycke Health Care ABCompletedCesarean Section; Complications, Wound, DehiscenceUnited States
-
Uludag UniversityUnknownCesarean Section Complications | Cesarean Wound Disruption | Cesarean Wound; DehiscenceTurkey
-
Kocaeli UniversityCompletedCesarean Section; Dehiscence | Cesarean Wound; DehiscenceTurkey
-
Ataturk UniversityUnknownCesarean Section Complications | Cesarean Section; Complications, Wound, Dehiscence | Cesarean Section, Repeated | Cesarean, Uterine Scar Thickness | Cesarean, Residual Myometrial ThicknessTurkey
-
Recep Tayyip Erdogan University Training and Research...CompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Northwell HealthCompletedCesarean Section Complications | Cesarean Wound Disruption | Cesarean Wound; DehiscenceUnited States
-
Menoufia UniversityCompletedCesarean Section | Wound Dehiscence
Clinical Trials on Standard Postoperative Medical Care
-
Saint Savvas Anticancer HospitalUnknownPostoperative Care | Intensive CareGreece
-
Sharif Medical Research CenterCompleted
-
Loyola UniversityCompletedOsteoarthritis (OA) of the KneeUnited States
-
University of CyprusUniversity of Crete; Nicosia General HospitalRecruiting
-
Centre Integre Universitaire de Sante et Services...Medtronic Spine LLCRecruitingSpine | Recovery Method | Post Surgery PatientsCanada
-
University of BaghdadRecruitingCongenital Heart Disease (CHD) | Postoperative Respiratory Dysfunction | Postoperative Recovery After Cardiac SurgeryIraq
-
Institut Cancerologie de l'OuestDirection Générale de l'Offre de SoinsCompletedPulmonary Complication | Surgical PatientsFrance
-
University Hospital, MontpellierCompletedPrimary Lymphedema Secondary LymphedemaFrance
-
Yang HuangThe Affiliated Brain Hospital of Nanjing Medical UniversityCompleted
-
Institute of Orthopaedic Surgery, Taizhou No.3...RecruitingHip Fracture | Elderly Patients | Postoperative Recovery | Nursing Interventions | Snyder Hope TheoryChina